AC Immune SA (ACIU) income statement
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.10−0.01 (-0.47%)
Close on Nov 18, 2026Market cap $213.66MP/E –Yield –
AC Immune SA income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -1940.1%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.93
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 27.7%
Valuation
- P/E ratio
- –
- Price to sales
- 50.16
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?